Distinguished in Coronary Heart Disease

Gilles Lemesle

Lille, FR 
Distinguished in Coronary Heart Disease
Lille, FR 
OverviewLocationsClinical Research

Overview

Gilles Lemesle practices in Lille, France. Mr. Lemesle is rated as a Distinguished expert by MediFind in the treatment of Coronary Heart Disease. His top areas of expertise are Heart Attack, Coronary Heart Disease, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

His clinical research consists of co-authoring 155 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 50 articles and participated in 1 clinical trial in the study of Coronary Heart Disease.

Gender
Male

Locations

Lille, 59000, France
Other Locations
Paris, France
INSERM UMRS 938, St. Denis, Jossigny, France
INSERM UMRS 1166, Université De Paris Est Créteil, Equipe 03, Metz, Clinique St. Martin And The Cardiology Department, CHU Clermont Ferrand, CNRS UMR 6602, Dijon, France
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Impact of an Intensive Care Diary on Post-traumatic Stress Disorder on Patients After a Resuscitated Sudden Death and His Relatives
Impact of an Intensive Care Diary on Post-traumatic Stress Disorder on Patients After a Resuscitated Sudden Death and His Relatives
Enrollment Status: Completed
Publish Date: December 16, 2025
Intervention Type: Other
Study Phase: Not Applicable
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Drug
Study Drugs: Cardiovascular Polypill, Treatment Prevention for Secondary CV
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
Enrollment Status: Completed
Publish Date: June 07, 2024
Intervention Type: Device
Study Phase: Phase 4
Myocardial Ischemia and Transfusion
Myocardial Ischemia and Transfusion
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Biological
Study Phase: Phase 3
View 4 Less Clinical Trials

155 Total Publications

Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
Journal: Circulation
Published: November 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lemesle's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile